The Venture Codex Logo

The Venture Codex

Overview

Biopharmaceutical company developing treatments across multiple areas.

Founded

2013

Deals ยท 12mo

3

Stage focus

Series A

Geographic focus

United States

Sector focus

Biotechnology
Financial Services
Health Care
Medical
...

Investment portfolio

49rounds
NAMEDATESIZE
Cloverleaf Bio
Sep 2026Participated
$33 MSeed
Third Arc Bio
Feb 2026Participated
$52 MSeries A
DISCO Pharmaceuticals
Dec 2025Participated
$42 MSeed
Light Horse Therapeutics
Jan 2025Participated
$62 MSeries A
Oisin Biotechnologies
Jul 2024Led
$15 MSeries A
Third Arc Bio
Jul 2024Participated
$165 MSeries A
Accent Therapeutics
Jan 2024Participated
$75 MSeries C
DISCO Pharmaceuticals
Jan 2024Participated
$22 MSeed
Quanta Therapeutics
Jun 2023Participated
$51 MSeries D
Mozart Therapeutics
Jun 2023Participated
$25 MSeries A
AmbAgon Therapeutics
Jan 2022Participated
$85 MSeries A
Nitrase Therapeutics
Nov 2021Participated
$45 MSeries A
Cloverleaf Bio
Sep 2026Participated
$33 MSeed
Third Arc Bio
Feb 2026Participated
$52 MSeries A
DISCO Pharmaceuticals
Dec 2025Participated
$42 MSeed
Light Horse Therapeutics
Jan 2025Participated
$62 MSeries A
Oisin Biotechnologies
Jul 2024Led
$15 MSeries A
Third Arc Bio
Jul 2024Participated
$165 MSeries A
Accent Therapeutics
Jan 2024Participated
$75 MSeries C
DISCO Pharmaceuticals
Jan 2024Participated
$22 MSeed
Quanta Therapeutics
Jun 2023Participated
$51 MSeries D
Mozart Therapeutics
Jun 2023Participated
$25 MSeries A
AmbAgon Therapeutics
Jan 2022Participated
$85 MSeries A
Nitrase Therapeutics
Nov 2021Participated
$45 MSeries A
49
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

AbbVie Ventures: 49 funding rounds are recorded in the selected participation categories.All available history.
AbbVie Ventures: 49 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed04
Series A621
Series B07
Series C+07
Other Equity04

Monthly Deal Activity

AbbVie Ventures: 49 deals are recorded across 161 months.All available history.
AbbVie Ventures: 49 deals are recorded across 161 months. All available history
MonthDeals
Jun '131
Jul '130
Aug '130
Sep '130
Oct '130
Nov '130
Dec '130
Jan '140
Feb '140
Mar '140
Apr '140
May '140
Jun '140
Jul '141
Aug '140
Sep '141
Oct '140
Nov '140
Dec '140
Jan '150
Feb '150
Mar '150
Apr '150
May '150
Jun '150
Jul '150
Aug '150
Sep '150
Oct '150
Nov '150
Dec '150
Jan '163
Feb '160
Mar '160
Apr '160
May '160
Jun '161
Jul '160
Aug '160
Sep '161
Oct '160
Nov '160
Dec '161
Jan '170
Feb '170
Mar '170
Apr '171
May '170
Jun '170
Jul '172
Aug '170
Sep '170
Oct '172
Nov '170
Dec '171
Jan '180
Feb '181
Mar '180
Apr '180
May '180
Jun '181
Jul '181
Aug '183
Sep '180
Oct '180
Nov '182
Dec '180
Jan '190
Feb '190
Mar '191
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '201
Feb '200
Mar '200
Apr '202
May '200
Jun '200
Jul '201
Aug '200
Sep '201
Oct '200
Nov '200
Dec '201
Jan '211
Feb '210
Mar '211
Apr '210
May '210
Jun '211
Jul '212
Aug '211
Sep '210
Oct '211
Nov '211
Dec '210
Jan '221
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '232
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '242
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '242
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '251
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '251
Jan '260
Feb '261
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '261
Oct '260

Sector Breakdown

AbbVie Ventures: Health & Life Sciences is the largest displayed sector by deal count (49 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

AbbVie Ventures: Health & Life Sciences is the largest displayed sector by deal count (49 deals). All available history
SectorDeals
Health & Life Sciences49
Manufacturing3
Space & Frontier Tech3
Consumer & Lifestyle1

Deal Size Distribution

AbbVie Ventures: 49 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

AbbVie Ventures: 49 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M5
$10M-$25M8
$25M-$50M15
$50M-$100M17
$100M-$250M4
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

AbbVie Ventures: United States has the largest recorded deal count among the displayed regions (41 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

AbbVie Ventures: United States has the largest recorded deal count among the displayed regions (41 deals). All available history
RegionDeals
United States41
Europe7
Australia1
AbbVie Ventures: 20 co-investors are shown, with Alexandria Venture Investments sharing 16 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Investment Strategy

AbbVie Ventures: Led accounts for 12% and participating for 88% of round participation.All available history.
AbbVie Ventures: Led accounts for 12% and participating for 88% of round participation. All available history
CategoryDeals (count)Share (%)
Led612%
Participating4388%
AbbVie Ventures: Single-lead accounts for 17% and co-led for 83% of lead dynamics.All available history.
AbbVie Ventures: Single-lead accounts for 17% and co-led for 83% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead117%
Co-led583%

Team

Axel Arosenius

Psychiatry Specialty Representative

James Holdsworth

Architect, Technology II

Margarita Chavez

Managing Director

Nicholas Donoghue

Executive Vice President, Chief Business and Strategy Officer

Ric A. Gonzalez

Chairman of the Board & Chief Executive Officer

Roopal Thakkar

Executive Vice President, Research & Development and Chief Scientific Officer

Sanjay Nilapwar

Principal Scientist

Tariq Ghayur

Distinguished Research Fellow

Vijay Raghavan

Associate Vice President, Marketing Analytics & Business Insights